RESUMO
Background: Hyperlipoproteinaemia is a metabolic abnormal condition and is largely regulated by Apolipoproteins types and subtypes. Moreover, lipoprotein abnormalities contribute significantly to the risk of developing cardio vascular disease and diabetes. Additionally, abnormal glycemic state, lipid and lipoprotein abnormalities have also been shown to contribute in early atherosclerosis
Objectives: Our present study evaluates the status of apolipo-protein A and B in hyperlipidemic patients with both diabetic and non-diabetic conditions
Methods: Study period was May 2006 to Dec 2007. 63 patients of both gender [males = 36, females = 27] sub-grouped as n = 46 non-diabetic hyperlipidemic [NDHL] and n = 17 diabetic hyperlipidemic [DHL] patients were included in the study. All parameters were determined with standard methods on IVD instruments with recommended pathological and normal controls
Results: Total cholesterol and Apo B was noted to be significantly higher in DHL than NDHL patients. Moreover, levels of Apo B was higher than Apo A in both DHL and NDHL groups when compared with Healthy group. Elevated levels of triglyceride and total cholesterol in both DHL and NDHL groups depicts a strong hyperlipidemic state
Conclusion: Conclusion were drawn from present study that diabetes and hyperlipidemia are important risk factors, in addition to the fact that higher levels of Apo B and A and that of higher Apo B than Apo A are indicative of dyslipidemic state and thus significant parameters for assessing the prevailing conditions and extent of risk for developing coronary heart disease [CHD] and atherosclerosis